Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 9-12 , 15 November 2004

MRI and CT in the diagnosis of vascular dementia

  • E.C.W. van Straaten

      Affiliations

    • Department of Neurology and Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 20 4443616.
    • ,
  • Ph. Scheltens

      Affiliations

    • Department of Neurology and Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands
    • ,
  • F. Barkhof

      Affiliations

    • Department of Radiology and Image Analysis Center, VU Medical Center, Amsterdam, The Netherlands

References 

  1. Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ. 2000;321(7274):1445–1449
  2. Rosler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal Bianco P, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ. 1999;318(7184):633–638
  3. Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998;50:136–145
  4. Scheltens P, Fox N, Barkhof F, De Carli C. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002;1:13–21
  5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
  6. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology. 1992;42:473–480
  7. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–260
  8. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch. Neurol. 1975;32:632–637
  9. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organisation; 1993;
  10. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch. Neurol. 2000;57:191–196
  11. van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke. 2003;34:1907–1912
  12. Auer DP, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology. 2001;218:443–451
  13. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am. J. Neuroradiol. 1999;20:637–642

PII: S0022-510X(04)00284-9

doi: 10.1016/j.jns.2004.09.003

Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 9-12 , 15 November 2004

Article Tools

* Image Usage & Resolution